Home › Funds › MEITAV INVESTMENT HOUSE LTD › TEVA

MEITAV INVESTMENT HOUSE LTD position in TEVA

TEVA PHARMACEUTICAL INDS LTD · Health Care

MEITAV INVESTMENT HOUSE LTD reported holding 9,947,045 shares of TEVA (TEVA PHARMACEUTICAL INDS LTD) in its Q2 2026 13F filing — a position valued at US$336.9M, representing 2.27% of its reported portfolio and ranking #8 among its reported holdings. MEITAV INVESTMENT HOUSE LTD has disclosed TEVA holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)9.95M sh
Reported value held$336.88M
Portfolio Weight2.27%
First reportedQ3 2023
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How MEITAV INVESTMENT HOUSE LTD's TEVA position evolved

MEITAV INVESTMENT HOUSE LTD first disclosed a stake in TEVA in Q3 2023 at 2,355,174 shares (US$24.3M). The position peaked in Q2 2026 at 9,947,045 shares, worth US$336.9M. Across 3 filings, MEITAV INVESTMENT HOUSE LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 9,947,045 shares valued at US$336.9M. Notable position changes include a 83% increase in Q4 2023 (shares rose 35% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.36M $24.25M New
Q4 2023 4.31M $44.91M Add
Q2 2026 9.95M $336.88M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About TEVA and 13F data

TEVA (TEVA PHARMACEUTICAL INDS LTD) is a Health Care company. 42 other funds we track also report a position in TEVA — the largest reported positions include Harel Insurance Investments & Financial Services Ltd. (US$1.63B), Phoenix Financial Ltd. (US$1.45B), WCM INVESTMENT MANAGEMENT, LLC (US$1.38B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding TEVA

All TEVA fund holders →

FAQ

How long has MEITAV INVESTMENT HOUSE LTD held TEVA?

MEITAV INVESTMENT HOUSE LTD has disclosed TEVA holdings in 3 of the last 12 reported quarters, going back to Q3 2023.

What is MEITAV INVESTMENT HOUSE LTD's current position in TEVA?

As of Q2 2026, MEITAV INVESTMENT HOUSE LTD holds 9.95M shares of TEVA (TEVA PHARMACEUTICAL INDS LTD), valued at $336.88M, representing 2.27% of its reported portfolio and ranking #8.

Has MEITAV INVESTMENT HOUSE LTD been buying or selling TEVA?

In the latest 13F filing (Q2 2026), MEITAV INVESTMENT HOUSE LTD newly opened its position in TEVA. The position peaked in Q2 2026 at 9.95M shares.

Which other funds hold TEVA?

Other major institutional holders of TEVA include Harel Insurance Investments & Financial Services Ltd., Phoenix Financial Ltd., WCM INVESTMENT MANAGEMENT, LLC, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.